Peer Review History
| Original SubmissionMarch 11, 2020 |
|---|
|
PONE-D-20-05739 Efficacy of Adding Activity of Daily Living Simulation Training to Traditional Pulmonary Rehabilitation on Dyspnea and Health-Related Quality-of-life PLOS ONE Dear Dr Wen-Chih Wu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by July 6, 2020. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Vinicius Cavalheri, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript called “Efficacy of Adding Activity of Daily Living Simulation Training to Traditional Pulmonary Rehabilitation on Dyspnea and Health-Related Quality-of-life” is very interesting and relevant to Pulmonary Rehabilitation area, but there are some considerations to do. It is reported below. Abstract: clear. Introduction: The authors explain the traditional pulmonary rehabilitation, justify the ADLs training needs but do not mention the energy conservation. What is energy conservation? Why energy conservation is important in this context? I’m asking it because “The aim of this study was to determine the impact of incorporation of ADL simulation and energy conservation practice in PR as part of a quality-initiative on dyspnea, fatigue, and health-related-quality-of-life (HRQOL) among PR patients.” Methods: The authors must define the acronyms used to describe the groups in the methods and, after that, they can use that on the tables. The description of ADL simulation and PR Groups is not clear. Do the baseline questionnaire (Self-Reported Task Difficulty) is validated instrument? The authors said “Therefore, in addition to the standard 12 weeks of twice weekly Traditional PR exercise and education sessions, ADL simulation intervention occurred in place of one regular Traditional PR session on a monthly basis for three months.” Was there a specific time to start the ADL simulation training? (example: 2 weeks after started the PR or every 2 weeks in each month) The Table 2 is not necessary, it could be described as part of the protocol, explaining the exercises. If the authors want to keep the table 2, they have to review the title (Table 2. Exercises Included in Energy Conservation Intervention) Where the Energy conservations are there? When and how the energy conservation was used? Results: How many records was assessed? How many was excluded and why? Table 1 the result of 6MWT distance is showed in ft. The usual way to report this measure is in meters. Why is not showed the p value for FEV1 and FEV1/FVC? Table 3 the authors need to review the CRQF’s data the difference between EC and TPR groups is too big. Table 4 - Although the p value was significant for Stairclimbing and Reaching, the standard deviations are very large, I recommend reviewing the statistic. The authors should explain at the end of each table the definition of all the acronyms used. Discussion: There are papers published about the results of PR on ADLs and about energy conservation could help the authors discuss their results strongly. Reviewer #2: This retrospective and observational study aimed to investigate the efficacy of a traditional PR added by an ADL simulation protocol on outcomes such as dyspnea, HRQOL and six-minute walk distance in subjects with chronic respiratory diseases. This is an interesting proposal since this topic of adding ADL simulation exercises to problematic ADLs in a PR program is innovative and it can contribute to the clinical practice. The manuscript is well written and the methodology is well organized. However, there are minor comments and some suggestions in order to improve the quality of the study. Comments: - This study reviewed medical records of a miscellaneous of respiratory diseases. In the authors’ opinion , may this study profile interfere in the results? How was the outcome differences of COPD and non-COPD subjects? Maybe this issue could be clearer in the article. - The tables in the article need to be self-explanatory. Hence, the authors should describe the definition of each abbreviation in the tables 1, 3 and 4. - The differences found on CAT and CRQ dyspnea are statistically significant, however, are they clinically relevant? - The baseline values of the six-minute walk distance are mismatched in table 1 and 3. These values should be revised. - Table 1 shows the baseline characteristics of the subjects between groups as well as the differences of those characteristics. There was any difference in the baseline scores of questionnaires of HRQOL? Maybe this information should be added in this table. - Along the text of the manuscript the table 2 is mentioned prior to table 1. Maybe this citation need to be revised. Reviewer #3: The study of Mahoney and colleagues investigated the addition of an ADL simulation protocol to PR on clinical outcomes in a variety of pulmonary diseases. The study was done collecting data retrospectively from an outpatient clinic. It is not clear, though, whether the data is from previous investigations or whether this is a real-life scenario. Authors conclude that the protocol provided additional benefits on quality of life and dyspnea. This is not, however, supported by the statistical treatment. Additionally, the temporal bias of the data collection was never mentioned in the manuscript. Specific comments are provided below. Page 4. The heterogeneity of the sample is worrisome. Patients with different ILD respond different to treatment and they all differ from COPD. It is difficult to know whether the training responses observed (or the lack thereof) are due to the protocol or due to the large variety of diseases. I recommend choosing only one disease (e.g. COPD) to be reported. Page 4. “ For this study, we only reviewed the records of patients who completed the 12 weeks of the PR program, which was 62% in 2017 and 58% in 2018.” Despite the retrospective design, it is a major limitation not having the data of attrition. If available, please include baseline characteristics of all patients (including dropouts) and describe reasons for non-completion of the protocol. Page 5. As per definition, primary outcome is only one. Authors report three (MMRC, CRQ and CAT). Page 7. “… between group differences in primary and secondary outcomes were compared using paired-sample and two-sample T tests respectively.” What exactly was compared between groups? Changes (Δ) or the assessments at week 12? A 2-way ANOVA seems more appropriate. The magnitude of differences (e.g. Cohen´s d test) is needed. Finally, it is recommended to report whether observed differences in changes are clinically relevant (i.e. exceeding MIDs of the tests). Page 9. “We found that incorporation of ADL simulation training into Traditional PR is superior to Traditional PR in significantly improving patient’s HRQOL measured by CAT score and CRQ Dyspnea score despite the lack of a significant difference in six-minute walk test.” This is not (yet) a conclusion of your study. Authors found significant differences in the ADL group. This, however, does not necessarily means there is superiority as statistical treatment is inadequate. Page 10. “ In addition, while patients were encouraged to practice resistance training specific to ADLs at home, it is likely that the compliance to these difficult exercises is low without on-site supervision.”. This remains controversial in the literature. Have you controlled it? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-05739R1 Efficacy of Adding Activity of Daily Living Simulation Training to Traditional Pulmonary Rehabilitation on Dyspnea and Health-Related Quality-of-life PLOS ONE Dear Dr. Wu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by 28 August 2020. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Vinicius Cavalheri, Ph.D., MSc Academic Editor PLOS ONE Additional Editor Comments (if provided): Dear Dr Wen-Chih Wu, Thank you for addressing the comments from the Reviewers. There are only two minor changes suggested by Reviewer #1. Can I please ask you to address the two minor changes? Many thanks [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript called “Efficacy of Adding Activity of Daily Living Simulation Training to Traditional Pulmonary Rehabilitation on Dyspnea and Health-Related Quality-of-life” improved after revision but remain some details that needs the authors attention. Methods: Pag 5-6 – “…Out of the 142 patients enrolled between October 2016 and August 2017 (pre-implementation period), 51 (35.9%) patients…, These patients…and personal reasons.” It is Results, not Methods. I suggest the authors transfer that paragraph to the beginning of results. Suggestion to reduce the study limitations – The authors said “The questionnaires used to assess HRQOL,15 dyspnea and fatigue were not validated for non-COPD patients” Looking the table 1 the authors has 59 COPD patients on EC-PR group and 54 on TPR group, the others chronic lung disease together adds 46 individuals in each group. The authors might do the separately analyzes of data COPD and not COPD. Perhaps the authors could do a separate analysis of COPD and non-COPD data. In my opinion, this will make the result stronger. Reviewer #3: The authors have made substantial improvement a to the manuscript. I believe the manuscript is now suitable for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Efficacy of Adding Activity of Daily Living Simulation Training to Traditional Pulmonary Rehabilitation on Dyspnea and Health-Related Quality-of-life PONE-D-20-05739R2 Dear Dr. Wu, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Vinicius Cavalheri, Ph.D., MSc, BSc (PT) Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-20-05739R2 Efficacy of Adding Activity of Daily Living Simulation Training to Traditional Pulmonary Rehabilitation on Dyspnea and Health-Related Quality-of-life Dear Dr. Wu: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Vinicius Cavalheri Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .